Showing results (191-200 of 343) with videos related to
Sort By:
Pageof 35
Plos One|February 8, 2022
Socio-demographic factors associated with early antenatal care visits among pregnant women in Malawi: 2004-2016Wingston Felix Ng'ambi, Joseph H Collins, Tim Colbourn, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV InfectionSarah Fidler, Ashley D Olson, Heiner C Bucher, et al.AIDS (London, England)|November 25, 2011
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapyJustyna D Kowalska, Joanne Reekie, Amanda Mocroft, et al.Antiviral Therapy|May 11, 2011
Predicting antiretroviral drug resistance from the latest or the cumulative genotypeFederico Garcia, Marta Alvarez, Zoe Fox, et al.Plos One|October 8, 2014
Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settingsAndrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.AIDS (London, England)|February 8, 2011
The impact of HIV drug resistance testing on changes to treatmentLoveleen Bansi, Colette Smith, Andrew Phillips, et al.AIDS (London, England)|February 23, 2007
Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?Paola Cicconi, Alessandro Cozzi-Lepri, Andrew Phillips, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.AIDS (London, England)|January 26, 2017
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavirSophie Jose, Mark Nelson, Andrew Phillips, et al.The Lancet. HIV|October 2, 2015
Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general populationAlec Miners, Andrew Phillips, Noemi Kreif, et al.Pageof 35